CHCHD2 activators are a specialized group of compounds that play a pivotal role in modulating the activity of the CHCHD2 protein. CHCHD2, a member of the coiled-coil-helix-coiled-coil-helix domain-containing protein family, is intricately involved in the regulation of mitochondrial function and cellular oxidative stress responses. The activators of CHCHD2 are not just chemical curiosities; they are essential tools for understanding the fundamental mechanisms of mitochondrial regulation. For instance, certain small molecule ligands that engage with CHCHD2 can enhance its interaction with mitochondrial DNA, leading to improved electron transport chain efficiency. These activators may work by stabilizing CHCHD2 in a conformation that favors its binding to partner proteins within the mitochondria, thereby bolstering its role in maintaining mitochondrial integrity. Other activators may influence post-translational modifications of CHCHD2, such as phosphorylation, effectively modulating its function and its interactions with other mitochondrial proteins. The precise biochemical mechanisms by which these activators function are critical to grasping the broader implications of CHCHD2's role in cellular metabolism and oxidative stress management.
Activators that impact the redox state of the cell offer another layer of regulation for CHCHD2. By altering the intracellular redox environment, these compounds can indirectly affect CHCHD2's activity. This modulation can lead to the enhancement of CHCHD2's protective effects against oxidative damage, which is crucial for the maintenance of mitochondrial dynamics and prevention of mitochondrial dysfunction. Furthermore, certain activators might influence the expression levels of CHCHD2 through the modulation of transcription factors that control the gene's expression, resulting in an increased abundance of the CHCHD2 protein and a subsequent uptick in its activity. It's important to note that the activation of CHCHD2 is a highly orchestrated event, and these chemical activators work in concert with the cell's intricate regulatory systems to ensure that the activity of CHCHD2 is precisely tuned to the cell's needs. This fine-tuning is vital for the preservation of cellular homeostasis, particularly in the face of stressors that challenge mitochondrial function and integrity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels which can enhance CHCHD2 activity via the cAMP-dependent pathway by activating PKA that can phosphorylate proteins, potentially influencing CHCHD2's mitochondrial functions. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, activates PKA. Activated PKA can then phosphorylate target proteins within the mitochondrial matrix, which may indirectly enhance CHCHD2's functional role in mitochondrial oxidative phosphorylation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, thereby activating PKA which could indirectly promote CHCHD2's role in mitochondrial signaling and biogenesis. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective phosphodiesterase inhibitor, which prevents cAMP degradation, possibly enhancing the phosphorylation status of proteins associated with CHCHD2's function in mitochondria. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK which can lead to the phosphorylation of mitochondrial proteins and may thereby indirectly enhance CHCHD2's role in mitochondrial respiratory function. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1 which can deacetylate proteins involved in mitochondrial function, potentially upregulating CHCHD2's activity in maintaining mitochondrial integrity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPAR-gamma agonist, indirectly influences mitochondrial biogenesis, which may enhance CHCHD2's role in energy production and mitochondrial gene expression. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Metformin activates AMPK which could indirectly influence mitochondrial biogenesis and function, potentially enhancing the activity of CHCHD2 within this organelle. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $197.00 $364.00 | 13 | |
SRT1720 is a SIRT1 activator, which may deacetylate mitochondrial proteins, possibly leading to an enhancement of CHCHD2's role in regulating mitochondrial dynamics and apoptosis. | ||||||
ZLN005 | 49671-76-3 | sc-474381A sc-474381 sc-474381B sc-474381C | 5 mg 10 mg 25 mg 50 mg | $45.00 $114.00 $159.00 $262.00 | ||
ZLN005 is a PPAR-beta/delta activator that could promote mitochondrial biogenesis, potentially enhancing CHCHD2's role in energy metabolism within the mitochondria. | ||||||